Stoke Therapeutics, Inc. (STOK) Financials
STOK Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 239.9 million | 66.9 million |
2023-06-30 | 256.9 million | 66.7 million |
2023-03-31 | 281.8 million | 68.0 million |
2022-12-31 | 256.1 million | 71.2 million |
STOK Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -17.6 million | 6.6 million |
2023-06-30 | -22.6 million | 6.8 million |
2023-03-31 | -21.5 million | 5.9 million |
2022-12-31 | -22.8 million | 5.8 million |
STOK Net Income
No data available :(
STOK Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 214.7 million | - | 2.5 million |
2023-06-30 | 231.4 million | - | 2.5 million |
2023-03-31 | 253.7 million | - | 2.4 million |
2022-12-31 | 229.6 million | - | 2.4 million |
STOK Shares Outstanding
STOK Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 383000 | 20.3 million | 10.3 million | - |
2023-06-30 | 839000 | 20.6 million | 10.2 million | - |
2023-03-31 | 165000 | 19.6 million | 10.2 million | - |
2022-12-31 | 409000 | 21.1 million | 9.4 million | - |
STOK Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 3.3 million | 1.2 million |
2023-06-30 | -2.5 million | 1.2 million |
2023-03-31 | 5.2 million | 1.1 million |
2022-12-31 | 3.3 million | 1.2 million |
STOK
Price: $11.69
52 week price:
Earnings Per Share: -2.38 USD
P/E Ratio: -1.81
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 66686
Market Capitalization: 558.8 million